Chittorgarh.com Logo
Loading...
Jul 15, 2022 - Jan 14, 2023

Marksans Pharma Ltd Buyback (Marksans Pharma Buyback) Detail

Marksans Pharma Ltd. is an Indian pharmaceutical company engaged in the research, manufacturing and marketing of finished dosage pharmaceutical formulations. The company employs the latest technology, automated manufacturing and packing operations and best practices, ensuring the highest quality of healthcare.

Marksans Pharma's manufacturing and R&D facility is located in Goa, India and in Southport, the UK for manufacturing non-sterile liquids, ointments and powder products.

The company has a footprint in the USA, Europe, South East Asia, Africa, Russia & CIS, Latin America and Australia.

Marksans Pharma Buyback Detail

Issue PeriodJul 15, 2022 - Jan 14, 2023
Security NameMarksans Pharma Ltd
Issue TypeOpen Market Through Stock Exchange
Issue Size (Amount)₹60.00 Crores
Buyback Price₹60 per share
Face Value₹1 per share
Listing AtBSE, NSE

Company Financials

Summary of financial Information (Consolidated)
Particulars For the year/period ended (Rs. in Lakhs)
  31-Mar-22 31-Mar-21 31-Mar-20
Total Income 1,53,269.20 1,38,287.61 1,13,453.67
Profit After Tax 18,681.40 23,853.88 12,075.27
Net Worth 1,04,216.44 86,972.58 61,990.88
Reserves and Surplus 99,623.30 82,379.44 57,397.74

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2022 48.1 38.7 44.28
May-2022 53.45 44.5 48.2
Apr-2022 62.35 45.55 55.56

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2022 48.1 38.6 44.15
May-2022 53.5 44.5 48.23
Apr-2022 62.4 45.5 56.03

Necessity of the Issue

The buyback is being undertaken for the following reasons:

1. The Buyback will help the Company to return surplus cash to its shareholders.

2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value.

Marksans Pharma Buyback Documents

Marksans Pharma Buyback Rating

4
2.5
Rating:Rated 2.5 stars
Vote Here ...

Marksans Pharma Buyback Reviews

Sorry, we couldn't find any reviews, please check back later.

Company Contact Information

Marksans Pharma Ltd
11th Floor,
Veera Desai Extension Road,
Oshiwara, Andheri (W), Mumbai - 400 053

Phone: +91 224001 2000
Email: info@marksanspharma.com
Website: http://marksanspharma.com/index.html

Marksans Pharma Buyback Registrar

  1. Bigshare Services Pvt Ltd
       1st Floor, Bharat Tin Works Building,
       Opp. Vasant Oasis,Makwana Road,
       Marol, Andheri(E), Mumbai - 400 059

    Phone: +91-22-6263 8200
    Email: investor@bigshareonline.com
    Website: http://www.bigshareonline.com

Marksans Pharma Buyback Manager

Lead Manager(s)

  1. Sundae Capital Advisors

Registered Broker

  1. Eureka Stock & Share Broking Services Limited
    Email:

Find Marksans Pharma Buyback Latest Update

Marksans Pharma Buyback FAQs

The Marksans Pharma Buyback opens on Jul 15, 2022, and closes on Jan 14, 2023.

The Marksans Pharma Buyback is a Open Market Through Stock Exchange.

Marksans Pharma Buyback Schedule

Buyback Opening DateJul 15, 2022
Buyback Closing DateJan 14, 2023
Last date for acceptance of sharesUpon relevant pay-out by the Stock exchange

The Marksans Pharma Buyback is being offered at Rs ₹60 per share per equity share.

There is no ratio applicable in case of open market offer through stock exchange mechanism.

There is no concept of record date in case of open market through stock exchange mechanism.

The Marksans Pharma Buyback has announced a buyback for an aggregate amount of not more than Rs. ₹60.00 Crores with pricing of Rs.₹60 per share.

The buyback is being undertaken for the following reasons:

1. The Buyback will help the Company to return surplus cash to its shareholders.

2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value.

Any equity shareholder holding the shares in Demat form can participate in the buyback offer through their stockbroker. The physical shareholder can participate only once the shares get converted into a Dematerialized form.

The shareholder needs to inform their broker on the details of the Equity shares they wish to sell. The broker will place a sell order whenever the company places a buy order for the buyback. The trade would get executed at the offer price or lesser only when the price offered by the shareholder matches with the buy order placed by the company.

The Marksans Pharma Buyback offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.


Comments

Add a public comment...